Ionis Pharmaceuticals
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Pioneering expertise in RNA- and DNA-targeted medicine discovery and development, rooted in a deep understanding of human genetics, to address serious diseases.
Description Brand's website · 2026-10-04
Ionis Pharmaceuticals is a pioneer in RNA- and DNA-targeted medicines, dedicated to discovering and delivering life-changing medicines for people living with serious diseases, with a deep understanding of genetics.
Offerings
Core capabilities Brand's website · 2026-10-04
RNA- and DNA-targeted medicines; includes TRYNGOLZA® (olezarsen) for severe hypertriglyceridemia (sHTG) and medicines under development for Angelman syndrome and other neurologic and cardiometabolic disorders.
Pricing Brand's website · 2026-10-04
Not disclosed
Audience
Target industry Brand's website · 2026-10-04
Patients living with serious, often intractable, diseases, including cardiometabolic disorders, neurologic conditions, and rare genetic diseases like Angelman syndrome and severe hypertriglyceridemia.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Ionis Pharmaceuticals's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Ionis Pharmaceuticals across the index.
Claim Ionis Pharmaceuticals — free →Page last updated 2026-10-17.